White label ELPA - ClinicalTrials.eu

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Not recruiting

3 1 1 1
Investigated drugs:
+3
Study on Valbenazine for Treating Dyskinesia in Children and Adults with Cerebral Palsy

Not recruiting

3 1
Investigated diseases:
Investigated drugs:
- Valbenazine Ditosylate
Study on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn’s Disease

Not recruiting

3 1
Investigated drugs:
- Upadacitinib
+13
Study of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis

Not recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
- Ixekizumab
- Adalimumab
+1
Study on the Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Children with Late-onset Pompe Disease

Not recruiting

3 1 1
Investigated diseases:
- Glycogen storage disease type II
Investigated drugs:
- Cipaglucosidase Alfa
- Miglustat
Study on Venetoclax, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study on the Effectiveness of Beclometasone, Glycopyrronium, and Formoterol in COPD Patients with Asthma Characteristics

Not recruiting

3 1 1 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
Study on Infertility: Comparing Corifollitropin Alfa and Follitropin Beta for Women Undergoing Elective Fertility Preservation

Not recruiting

3 1 1 1
Investigated diseases:
- Infertility
Investigated drugs:
Study on the Effectiveness and Safety of Bevacizumab, Atezolizumab, and RO7247669 in Patients with Resectable Liver Cancer

Not recruiting

1 1 1 1
Investigated diseases:
- Hepatocellular carcinoma
Investigated drugs:
Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

Not recruiting

3 1 1 1
Investigated diseases:
- Essential thrombocythaemia
- Thrombocytosis
Investigated drugs:
- Ropeginterferon Alfa-2B
+4

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies